Amplifon, IT0004056880

Amplifon stock holds firm as H1 2026 growth supports valuation

Published on 09/20/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock trades around the mid-11-euro range on Borsa Italiana as of September 19, 2026, supported by solid H1 2026 revenue growth. The shares remain below analyst targets near 16.70 euros while market capitalization stays in the multi-billion-euro bracket.

Modernes Hörzentrum mit Beratungsraum und Hörgeräte-Ausstellung, fotorealistisch
Fotorealistisches Bild zeigt modernen Hörzentrum-Ladenraum, passend zu Amplifon S.p.A. mit ISIN IT0004056880, Sektor Medizintechnik, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) is trading around EUR 11.35 on Borsa Italiana as of September 19, 2026, leaving the hearing-care specialist valued in the multi-billion-euro range and some distance below bullish analyst targets near EUR 16.70.

Stock price and market positioning

Based on recent data for the primary listing in Milan, Amplifon stock changed hands at around EUR 11.35 on September 19, 2026, representing a modest daily decline of about 0.78 percent compared with the prior close on Borsa Italiana.

The same snapshot places the shares clearly above the lower end of their 52-week trading range but still below recent highs, indicating that investors are cautious despite supportive fundamentals. The market capitalization stood at roughly EUR 2,600,000,000 as of September 19, 2026, underscoring Amplifon's role as a mid-cap player within the Italian equity landscape.

H1 2026 figures underpin the equity story

For context, Amplifon reported its most recent half-year figures for H1 2026 earlier in the year, with revenue growth and profitability trends forming the basis for current analyst models and valuation ranges. Although the detailed H1 2026 numbers are not restated in the latest week-filtered sources, coverage repeatedly highlights that the company delivered solid top-line expansion in the first six months of 2026 compared with H1 2025, which helps justify price targets above the current share level.

In particular, investor focus has shifted to whether Amplifon can translate its historical revenue momentum into sustained margin resilience in the face of inflation, wage pressures and store network investments. The hearing-care market remains structurally attractive, and Amplifon's global footprint provides diversification, but the valuation premium implied by targets near EUR 16.70 requires continued execution on operating leverage and cash generation.

Analyst stance and valuation gap

According to the latest capitalisation overview from Il Sole 24 Ore on September 20, 2026, Amplifon is classified with a Buy recommendation, and its market capitalization is listed around EUR 4,533,000,000, indicating that at least one analyst house sees upside potential from the current trading band.

The difference between this roughly EUR 4.53 billion valuation and the lower EUR 2.60 billion figure referenced in earlier data illustrates that estimates and methodologies can vary, but both point to a sizeable equity value underpinned by Amplifon's global retail and service platform. More importantly for investors, the gap between the current share price of about EUR 11.35 and high price targets near EUR 16.70 amounts to roughly 47 percent potential upside if the company meets expectations on earnings and cash flow over the coming quarters.

Sector context and risk factors

Within Italy's consumer and healthcare-related segments, Amplifon competes for capital with other mid-cap names that have also delivered robust revenue trends but face similar macro headwinds. Rising interest rates and selective risk appetite could limit multiple expansion even if Amplifon continues to grow its top line at a healthy pace. In addition, any slowdown in discretionary healthcare spending or delays in clinic and store openings would likely weigh on the company's ability to close the valuation gap implied by analyst targets.

On the operational side, Amplifon's strategy rests on dense retail coverage, strong relationships with device manufacturers and ongoing investments in digital tools to improve the customer journey. These factors support recurring revenue streams, but they also entail higher fixed costs, meaning that margin progression is sensitive to volume growth and pricing discipline. For investors, the balancing act between growth investments and profitability will remain a central point of attention when the company next updates the market.

Stock level as of the latest trading day

As of September 19, 2026, Amplifon stock is trading at around EUR 11.35 on Borsa Italiana, leaving it above the lower end of its 52-week range but still below recent highs and below analyst price targets near EUR 16.70, with a market capitalization measured in the billions of euros.

Amplifon stock - key data

  • Company: Amplifon S.p.A.
  • ISIN: IT0004056880
  • Ticker: AMP
  • Trading venue: Borsa Italiana
  • Price (as of September 19, 2026, 09:56): 11.35 EUR
  • Market capitalization: 2,600,000,000 EUR (as of September 19, 2026)
  • Sector / Industry: Healthcare - Hearing care services
  • Index membership: FTSE MIB

More news and analyses on Amplifon stock

Disclaimer...

en | IT0004056880 | AMPLIFON | boerse | 70135872 | bgmi